BR100 Decreased By (-0.15%)
BR30 Decreased By (-0.74%)
KSE100 Decreased By (-0.41%)
KSE30 Decreased By (-0.67%)
BECO 5.80 Decreased By ▼ -0.23 (-3.81%)
BML 58.03 Increased By ▲ 5.28 (10.01%)
BOP 33.85 Decreased By ▼ -0.40 (-1.17%)
CNERGY 8.15 Decreased By ▼ -0.01 (-0.12%)
DCL 11.77 Decreased By ▼ -0.57 (-4.62%)
FCCL 53.35 Decreased By ▼ -0.54 (-1%)
FCSC 5.40 Increased By ▲ 0.18 (3.45%)
FFL 17.89 Decreased By ▼ -0.14 (-0.78%)
FNEL 1.31 Increased By ▲ 0.01 (0.77%)
HUMNL 11.06 Increased By ▲ 0.06 (0.55%)
KEL 8.05 Decreased By ▼ -0.06 (-0.74%)
KOSM 5.45 Increased By ▲ 0.07 (1.3%)
MLCF 87.19 Decreased By ▼ -0.86 (-0.98%)
NBP 184.60 Decreased By ▼ -1.88 (-1.01%)
PACE 11.62 Increased By ▲ 0.90 (8.4%)
PAEL 40.31 Increased By ▲ 0.37 (0.93%)
PIAHCLA 26.10 Decreased By ▼ -0.07 (-0.27%)
PIBTL 17.09 Decreased By ▼ -0.23 (-1.33%)
PPL 228.40 Decreased By ▼ -4.38 (-1.88%)
PRL 34.59 Decreased By ▼ -0.36 (-1.03%)
PTC 67.35 Decreased By ▼ -0.21 (-0.31%)
SEARL 91.00 Increased By ▲ 0.07 (0.08%)
SSGC 26.90 Decreased By ▼ -0.27 (-0.99%)
TELE 8.53 Decreased By ▼ -0.04 (-0.47%)
THCCL 66.14 Increased By ▲ 6.01 (10%)
TPLP 9.29 Increased By ▲ 0.53 (6.05%)
TREET 24.59 Increased By ▲ 0.05 (0.2%)
TRG 71.69 Decreased By ▼ -0.06 (-0.08%)
WAVES 10.98 Increased By ▲ 1.00 (10.02%)
WTL 1.28 Increased By ▲ 0.02 (1.59%)
By

FRANKFURT: European stocks closed higher on Tuesday, buoyed by financials and defence stocks, though Danish stocks logged their biggest one-day drop of the year as Novo Nordisk’s shares slid after the weight-loss drug maker issued a profit warning.

The Wegovy producer, once a market darling, logged its biggest one-day drop on record of 23%, wiping about $57.5 billion off its market value, as it slashed its outlook for 2025 sales growth and named a new CEO as it battles rising competition in the obesity drug market.

The stock weighed on Denmark’s Copenhagen OMX index , which lost 11.9%, while the broader STOXX pharmaceutical sector slid 1.6%.

“It’s doubly disappointing for investors when you find a company that had been anticipated to be a real star in a booming sector, and they don’t seem to be able to capitalize on what was a really good competitive position,” said Danni Hewson, head of financial analysis at AJ Bell.

The stock “seems to be getting pummeled” by its US rival, Eli Lilly, Hewson said. “Now we are seeing a change in CEO, but investors are not going to give the new guy an awful lot of time to get the house in order.”

Eli Lilly also lost 5% in afternoon trading.

More broadly the pan-European STOXX 600 index finished 0.3% higher, with banks gaining 1.7% to hit their highest since September 2008 as investors bet on improved profits and resilience in a sector broadly insulated from tariff turmoil.

In a relief for investors, the US and EU signed an agreement to lower US tariffs to 15%, ending weeks of negotiations earlier this week and offering investors some clarity on the trade front.

Analysts said the corporate earnings landscape has markedly improved following the deal, and they now project European companies to deliver 1.8% growth in second-quarter earnings compared to a 0.3% decline just a week earlier, according to LSEG I/B/E/S data.

Aerospace and defence stocks added 2.2% after three straight days of losses. The new framework trade deal offered zero-for-zero tariffs on aircraft and parts. Airbus and Safran SA gained 1.7% and 2.1%, respectively.

Franco-Italian eyewear group EssilorLuxottica shares jumped 6.9% after the company reported an increase in first-half operating profit despite a tariff hit.

Dutch company Philips rose 9.2% to the top of the index after the healthcare technology group lowered its tariff impact estimates following the US-EU trade deal.

Attention now turns to Wednesday’s second-quarter GDP releases from both the euro zone and the US, followed by the Federal Reserve’s highly anticipated rate decision and Friday’s US employment report.

Comments

Comments are closed for this article.